Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 15, Issue 1, Pages 30-37Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2012.10.026
Keywords
Lactobacillus casei Zhang; Lipopolysaccharide; D-Galactosamine; Liver injury; THF-alpha; TLR4
Categories
Funding
- National Natural Science Foundation of China [31025019, 30801001, 31270922, 81260622]
- China Postdoctoral Science Foundation [20110491553]
- Innovation Team Development of the Ministry of Education of China [IRT0967]
- China Agriculture Research System [CARS-37]
Ask authors/readers for more resources
Lactobacillus casei Zhang (LcZ) has been recently isolated from the traditional Mongolian beverage koumiss and has a set of favorable probiotic properties, including aciduricity, bile resistance and ability to colonize the gastrointestinal tract. We have previously reported the anti-oxidative properties of LcZ in the hyperlipidemic rats. In this study, the hepatoprotective effects of LcZ against lipopolysaccharide (LPS) and D-galactosamine (D-GalN)-induced liver injury were investigated. We found that pretreatment with LcZ significantly improved survival of rats challenged with LPS/D-GalN. In addition, pretreatment with LcZ significantly decreased alanine transaminase (ALT) and aspartate aminotransferase (AST) levels in LPS/D-GalN-challenged rats, which were accompanied by diminished liver injuries, reduced malondialdehyde (MDA) content and increased superoxide dismutase (SOD) activity in liver homogenates. Pretreatment with LcZ also markedly reduced LPS/D-GalN-induced production of hepatic nitric oxide (NO), activation of inducible nitric oxide synthase (iNOS) and expression of tumor necrosis factor-alpha (TNF-alpha). Furthermore, hepatic toll-like receptor 4 (TLR4) mRNA and protein levels, the phosphorylation of I-kappa B and translocation of nuclear factor kappa B (NF-kappa B) were significantly down-regulated by pretreatment with LcZ. These results suggest that pretreatment with LcZ protects against LPS/D-GalN-induced liver injury in rats via its anti-oxidative and anti-inflammatory capacities. The hepatoprotective effects of LcZ are associated with an inhibition of TLR4 expression and TLR4 signaling. (C) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available